1. Hypoxia-inducible Factor 1α Expression Correlates with Angiogenesis and Unfavorable Prognosis in Bladder Cancer

Vasilios E. Theodoropoulos, Andreas Ch. Lazaris, Fragiskos Sofras, Ioannis Gerzelis, Vasiliki Tsoukala, Ioanna Ghikonti, Konstantinos Manikas, Ioannis Kastriotis

European Urology, Volume 46, Issue 2, August 2004, pages 200-8

2. Evaluation of HIF-1alpha overexpression as a predictor of tumour reccurence and progression in superficial urothelial bladder carcinoma

V.E. Theodoropoulos, A.C. Lazaris, I. Kastriotis, C. Spiliadi, G.E. Theodoropoulos, V. Tsoukala, E. Patsouris, F. Sofras

BJU International, Volume 95, Issue 3, February 2005, pages 425-431

3. Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma. Prognostic implications.

V.E. Theodoropoulos, A. Tsigka, A. Mihalopoulou, V. Tsoukala, A.C. Lazaris, E. Patsouris, I. Ghikonti

Urology, 2005 Oct;66(4):897-902.

4. Hypoxia and apoptosis with bcl-2 expression in urothelial bladder carcinoma

V.E. Theodoropoulos, A.C. Lazaris, I. Gerzelis, I. Ghikonti, A. Tsigka, V. Tsoukala, F. Sofras, E. Patsouris, I. Kastriotis

Medimond S.r.l. – Monduzzi Editore International Proceedings Division, 

The Third International Conference on “TUMOR MICROENVIRONMENT: PROGRESSION, THERAPY 

AND PREVENTION” 

October 12-16, 2004, Prague, Czech Republic

5. Vascular endothelial growth factor expression in primary superficial bladder cancer and its relationship to p53 nuclear protein accumulation: prognostic implications

Vasilios E. Theodoropoulos, Andreas Ch. Lazaris, Ioannis Gerzelis, Vasiliki Tsoukala, Ioanna Ghikonti, Konstantinos Manikas, Fragiskos Sofras, Ioannis Kastriotis

European Surgical Research, Volume 36, suppl 1, May 2004, page 127

6. A study of the relation between HIF-1α immunoreactivity, Ki-67 labeling and clinical outcome in urothelial bladder carcinoma

Vasilios E. Theodoropoulos, Andreas Ch. Lazaris, Konstantinos Manikas, Ioannis Gerzelis, Vasiliki Tsoukala, Ioanna Ghikonti, Ioannis Kastriotis, Fragiskos Sofras

European Surgical Research, Volume 36, suppl 1, May 2004, page 126

7. The combination of Hif-1α overexpression with p53 protein dysfunction is a marker for an unfavorable prognosis in urothelial bladder carcinoma

Manikas K, Theodoropoulos V, Lazaris A, Tsoukala V, Gerzelis I, Ghikonti I, Sofras F, Kastriotis I

BJU International, Volume 94, suppl 2, October 2004, page 239

8. Apoptosis in urothelial bladder carcinomas and its relation to the expression of caspase 3 and apoptosis regulating proteins bax and bcl-2: prognostic implications

Theodoropoulos V.E.¹, Lazaris A.C.³, Ghikonti I.², Tsoukala V.³, Chamilos E¹. Tamvakos G. ¹, Aleksandrakis K. ¹, Gerzelis J.¹, Sofras F.⁴, Kastriotis J.⁵

¹Departments of Urology and ²Pathology, Agia Olga General Hospital, Athens, Greece, ³Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Greece, ⁴Department of Urology, University General Hospital of Heraklion, Greece, ⁵Department of Urology, Sismanoglio Hospital, School of Medicine, National and Kapodistrian University of Athens Athens, Greece

European Journal of Cancer Supplements, Volume 3, Issue 2, October 2005, Page 252

9. Plasma D- dimer level and stage of primary lung cancer

G.Pavlakou, V.Tsoukala, A.Sakellaropoulos, D.Antoniou, S.Tsimboukis, E.Tsaroucha O.Anagnostopoulou 8^th Department of Chest Diseases. Hospital of Chest Diseases, Athens , Greece,

European Respiratory Journal Suppl, 2003

10. The administration of nebulised racemic epinephrine in asthma exacerbations

G.Pavlakou, S,Tsimboukis, D.Antoniou, V.Tsoukala, E.Tsaroucha, M.Palavra, O.Anagnostopoulou 8^th ,7^th , Hospital of Chest Diseases of Athens, CREECE

European Respiratory Journal Suppl, 2004